Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 30;7(1):2519.
doi: 10.1038/s41598-017-02707-y.

Close linkage between serum uric acid and cardiac dysfunction in patients with ischemic heart disease according to covariance structure analysis

Affiliations

Close linkage between serum uric acid and cardiac dysfunction in patients with ischemic heart disease according to covariance structure analysis

Yoshiro Tanaka et al. Sci Rep. .

Abstract

High serum uric acid (UA) level has been assumed to be a risk factor for left ventricular (LV) dysfunction; however, the precise relationship between these conditions has not been fully examined because many confounding factors are associated with UA level. We herein examined the precise relationship by proposing structural equation models. The study population consisted of 1432 cases with ischemic heart disease who underwent cardiac catheterization. Multiple regression analyses and covariance structure analyses were performed to elucidate the cause-and-effect relationship between UA level and LV ejection fraction (LVEF). A path model exploring the factors contributing to LVEF showed that high UA was a significant cause of reduced LVEF (P = 0.004), independent of other significant factors. The degree of atherosclerosis, as estimated by the number of diseased coronary vessels, was significantly affected by high UA (P = 0.005); and the number of diseased coronary vessels subsequently led to reduced LVEF (P < 0.001). Another path model exploring the factors contributing to UA level showed that LVEF was a significant cause of high UA (P = 0.001), while other risk factors were also independent contributing factors. This study clearly demonstrated that there was a close link between high UA and LV dysfunction, which was represented by possible cause-and-effect relationship.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
The path model [A]: An explanatory drawing of the possible cascade from risk factors to the number of diseased vessels and LVEF. This path has a coefficient showing the standardized coefficient of a regressing independent variable on a dependent variable of the relevant path. These variables indicate standardized regression coefficients (direct effect) [bold typeface indicates remarkable values], squared multiple correlations [narrow italics] and correlations among exogenous variables [green]. BMI, body mass index; TG, triglyceride; AOsys, systolic blood pressure; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; UA, uric acid; e, extraneous variable.
Figure 2
Figure 2
The path model [B]. An explanatory drawing of the possible cascade from risk factors to UA. Each path has a coefficient showing the standardized coefficient of a regressing independent variable on a dependent variable of the relevant path. These variables indicate standardized regression coefficients (direct effect) [bold typeface indicates remarkable values], squared multiple correlations [narrow italics] and correlations among exogenous variables [green].

References

    1. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811–1821. doi: 10.1056/NEJMra0800885. - DOI - PMC - PubMed
    1. Doehner W, Jankowska EA, Springer J, Lainscak M, Anker SD. Uric acid and xanthine oxidase in heart failure - Emerging data and therapeutic implications. Int J Cardiol. 2016;213:15–19. doi: 10.1016/j.ijcard.2015.08.089. - DOI - PubMed
    1. Volterrani M, Iellamo F, Sposato B, Romeo F. Uric acid lowering therapy in cardiovascular diseases. Int J Cardiol. 2016;213:20–22. doi: 10.1016/j.ijcard.2015.08.088. - DOI - PubMed
    1. Kang DH, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002;13:2888–2897. doi: 10.1097/01.ASN.0000034910.58454.FD. - DOI - PubMed
    1. Uchida S, et al. Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease–A Propensity Score Analysis. PLOS ONE. 2015;10:e0145506. doi: 10.1371/journal.pone.0145506. - DOI - PMC - PubMed

LinkOut - more resources